Further studies indicated that the TP53 mutations in women never smokers with adenocarcinoma were predominantly transitions (83%); however, in smokers, the mutations were predominantly transversions (60%) and deletions (20%) [204]. The gene discussed is TP53; the disease is adenocarcinoma.